Description of Collaborative Activity: |
Through an Inter-Agency Agreement, the FDA provides structure-activity relationship-based toxicity predictions for compounds that are under evaluation in the NIDA Addiction Treatment Discovery Program. On a limited basis, other NIH institutes and centers may utilize this resource by working through NIDA. |